Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Dow Surges 400 Points; Crude Oil Down 1% ↗

November 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Via Benzinga

Why Verve Therapeutics' Stock Dropped 26.33% on Monday ↗

November 07, 2022

A trial for the company's lead therapy was put on hold.

Via The Motley Fool

Why Shares Of CRISPR-Focused Verve Therapeutics Just Took A Grim Turn ↗

October 31, 2022

The company is testing a CRISPR-based approach to high cholesterol.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Looking Into Verve Therapeutics's Recent Short Interest ↗

November 07, 2022

Verve Therapeutics's (NASDAQ:VERV) short percent of float has fallen 11.53% since its last report. The company recently reported that it has 10.73 million shares sold short, which is 33.6% of all...

Via Benzinga

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet ↗

November 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Dow Up Triple Digits Ahead Of Busy Week ↗

November 07, 2022

The Dow Jones Industrial Average is up 212 points midday, continuing Friday's flourish, while the Nasdaq Composite and S&P 500 Index sit more hesitantly in the black.

Via Talk Markets

IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal ↗

November 07, 2022

IAA (IAA) stock is moving on Monday thanks to a massive acquisition $7.3 billion deal with Ritchie Bros Auctioneers (RBA).

Via InvestorPlace

Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate ↗

November 07, 2022

Via Benzinga

Why Is Verve Therapeutics (VERV) Stock Down 28% Today? ↗

November 07, 2022

Verve Therapeutics (VERV) stock is taking a beating on Monday following bad news from the U.S. Food and Drug Administration (FDA).

Via InvestorPlace

TreeHouse Foods, Ritchie Bros. Auctioneers, Beam Therapeutics And Some Other Big Stocks Moving Lower On Monday ↗

November 07, 2022

U.S. stocks traded mostly higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Mixed; Dow Rises Over 50 Points ↗

November 07, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Via Benzinga

Verve Crashes After FDA Halts Plan To Test Gene Editor In People ↗

November 07, 2022

Verve Therapeutics hopes to use a next-generation form of CRISPR called base editing.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 07, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 07, 2022

Good morning, investor! We're diving into the biggest pre-market stock movers for Monday as we get ready for another week of trading!

Via InvestorPlace

Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results

November 07, 2022

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics Announces Publication of VERVE-101 Preclinical Data in Circulation and Presentations at the American Heart Association Annual Meeting

October 31, 2022

Verve Researchers Awarded Paul Dudley White International Scholar Award from the American Heart Association for Highest Ranked Abstract Submitted from the United States to Scientific Sessions 2022

From Verve Therapeutics

Via GlobeNewswire

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures? ↗

October 20, 2022

Despite enthusiasm in some camps, the risk of potential cures clouds market projections.

Via Investor's Business Daily

A Look Into Healthcare Sector Value Stocks ↗

October 10, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" Competition ↗

October 06, 2022

Via Benzinga

Cathie Wood Just Bought the TSLA Stock Dip. Should You? ↗

October 04, 2022

Cathie Wood is doubling down on TSLA stock. Here's why investors may want to follow her lead before markets shift in 2023.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

October 03, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 ↗

October 06, 2022

Upgrades

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

September 30, 2022

There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public.

Via InvestorPlace

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

Amazon, bluebird bio And 3 Stocks To Watch Heading Into Monday ↗

September 26, 2022

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Cathie Wood Loads Up $23M Worth Of Shares In This Gene-Editing Company As Stock Falls Over 10% In A Month ↗

September 25, 2022

Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.